Boston Scientific profit beats estimates as cardiovascular sales surge

Sales of the Marlborough, Mass. company’s cardiovascular products rose 17.8% to $2.64 billion.

Previous post GE Vernova beats on profit with first standalone results, despite wind weakness
Next post Bitcoin hovers near $66.5k as Mt.Gox users ‘choose to hodl’